课题基金 / 基金详情

Preventing Injecting and Overdose by Disrupting Injection Drug Use Transitions: The PRIMER II Study

Preventing Injecting and Overdose by Disrupting Injection Drug Use Transitions: The PRIMER II Study
通过破坏注射药物使用转变来预防注射和用药过量:PRIMER II 研究
批准号:
434750
负责人:
Werb Daniel M
金额:
$55.45万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2020
资助国家:
加拿大
项目状态:
未结题
起止时间:
2020-10-01 至 2025-10-01

项目摘要

项目成果

Werb Daniel M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Injection drug use is a key risk factor for overdose death, so preventing people from initiating injection drug use would reduce the unacceptably high death toll due to the opioid overdose epidemic. At present, though, there are no effective and scalable
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Toronto Disparities, Overdose, and Treatment (T-DOT) Study: Investigating clinical outcomes among people who inject drugs during a period of rapid programmatic and policy change
  • 批准号:
    462231
  • 项目类别:
    Operating Grants
  • 资助金额:
    $113.69万
  • 财政年份:
    2022
  • 负责人:
    Werb Daniel M
  • 依托单位:
Rapidly assessing the impact of the COVID-19 pandemic and response on clinical and social outcomes, service utilization, and the unregulated drug supply experienced by people who use drugs in Toronto
  • 批准号:
    430301
  • 项目类别:
    Operating Grants
  • 资助金额:
    $15.06万
  • 财政年份:
    2020
  • 负责人:
    Werb Daniel M
  • 依托单位:
A proposal to evaluate safer supply pilot programs in Canada
  • 批准号:
    441626
  • 项目类别:
    Operating Grants
  • 资助金额:
    $87.15万
  • 财政年份:
    2020
  • 负责人:
    Werb Daniel M
  • 依托单位:
海外基金